Associated Papers
Alterations in the Smad pathway in human cancers.
Samanta D et al.
Frontiers in Bioscience (landmark Edition), 2012
Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression.
Belaguli NS et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology, 2007
A mechanism for mutational inactivation of the homeodomain protein TGIF in holoprosencephaly.
Ferrand N et al.
Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2007
Formation of a stable heterodimer between Smad2 and Smad4.
Wu JW et al.
The Journal of Biological Chemistry, 2001
Mechanism for mutational inactivation of the tumor suppressor Smad2.
Prunier C et al.
Molecular and Cellular Biology, 2001
Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion.
Prunier C et al.
The Journal of Biological Chemistry, 1999
Dominant-negative Smad2 mutants inhibit activin/Vg1 signaling and disrupt axis formation in Xenopus.
Hoodless PA et al.
Developmental Biology, 1999
TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads.
Hata A et al.
Molecular Medicine Today, 1998
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.
Eppert K et al.
Cell, 1996
Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.
Levy L et al.
Cytokine & Growth Factor Reviews, 0
Select a paper to view details